FirstWord Pharma: Cirius Therapeutics Announces Positive Data for MPC Inhibitor 0602K Alone and in Combination with Tirzepatide Shared By: contributorJune 23, 2025 Ralph A. DeFronzo, MD, professor of medicine, and chief, Diabetes Division, was quoted in this article. Read More Share This Article!
